Cell-adhesion molecules, glucocorticoids and long-term-memory formation

Trends in Neurosciences
S P Rose

Abstract

The transition from short- to long-term memory requires lasting modulations of synaptic connectivity. In a variety of species and learning tasks, enhanced synthesis of glycoprotein cell-adhesion molecules (CAMs), such as neural CAM (NCAM) and Ll, 5-8 h post-training is a necessary step in this process. If the training event is weak, this phase of glycoprotein synthesis does not occur and memory is not retained. Antibodies or fragments that bind to the extracellular domains of NCAM or Ll at this time produce amnesia for the task. Centrally administered corticosterone enhances retention of weak learning, and steroid-receptor antagonists are amnestic. The effects of corticosterone are mediated through synthesis of 'second-wave' glycoproteins. As 'nootropic' drugs such as piracetam only enhance long-term retention and are ineffective in adrenalectomized animals, the interaction between glucocorticoids and glycoproteins might provide a site for pharmacological intervention in alleviating the losses of memory that occur in neurodegenerative disorders.

References

May 1, 1995·Trends in Neurosciences·J DeZazzo, T Tully
Mar 1, 1995·Journal of Neurobiology·P DohertyF S Walsh
Apr 1, 1995·Trends in Neurosciences·E V WongV Lemmon
Sep 1, 1994·Neurobiology of Aging·D Linnemann, T Skarsfelt
Oct 20, 1994·Nature·L CahillJ L McGaugh
Aug 1, 1994·The European Journal of Neuroscience·C Sandi, S P Rose
May 1, 1994·Brain Research. Brain Research Reviews·A H Gouliaev, A Senning
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·C MondadoriJ Borkowski
Jan 1, 1992·The European Journal of Neuroscience·Friedrich Von Bohlen Und HalbachMelitta Schachner
Nov 1, 2008·The European Journal of Neuroscience·Carmen Sandi

❮ Previous
Next ❯

Citations

Mar 15, 1997·Journal of Neuroscience Research·A H ZischE B Pasquale
Dec 13, 2002·Journal of Neuroscience Research·Ulla JessenElisabeth Bock
Mar 10, 2004·Neurobiology of Disease·Laura TodaroEugenia Sacerdote de Lustig
Oct 18, 2000·European Journal of Pharmacology·M P Vawter
Nov 1, 1996·Physiology & Behavior·R McKenzie, R J Andrew
May 22, 2003·Pharmacology, Biochemistry, and Behavior·Véronique AginMarie Paule Chichery
Jan 1, 1997·Clinical Therapeutics·H AllainS Belliard
Sep 1, 1997·Neuroscience·R O SolomoniaG Horn
Jun 28, 2001·Brain Research Bulletin·G Székely
May 30, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·G Johnson, S W Moore
Feb 7, 1998·Current Opinion in Neurobiology·J Z Kiss, G Rougon
Dec 13, 2003·Neurobiology of Learning and Memory·Herman T EpsteinDaniel L Alkon
Dec 21, 2000·The European Journal of Neuroscience·R MileusnicS P Rose
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·H CremerP M Lledo
Jun 5, 2001·Neuroreport·S YanagiharaT Matsushima
Feb 24, 2001·Behavioural Pharmacology·I Izquierdo, J L McGaugh
Aug 4, 2005·Learning & Memory·Karin RichterMario Engelmann
Jan 28, 2005·The European Journal of Neuroscience·Shira KnafoCésar Venero
Jun 4, 1998·Journal of Medical Genetics·E FransenP J Willems
Mar 10, 2000·Pediatric Research·S G Matthews
Apr 30, 2003·Zoological Science·Toshiya MatsushimaShin Yanagihara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cavernous Hemangioma

Cavernous hemangioma is a blood vessel defect or benign tumor that leads to leakage of blood to the surrounding tissues. This can occur in several organs including the brain, which can lead to seizures. Discover the latest research on cavernous hemangiomas here.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.